MedTrace Logo

MRI Following Stereotactic Radiosurgery (SRS) for Brain Metastases

NCT04246879 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2026-05-06

No results posted yet for this study

Summary

The purpose of this study is to test whether an additional magnetic resonance image (MRI) sequence can improve the ability to distinguish radiation damage from tumor recurrence in participants with brain metastasis who have previously been treated with stereotactic radiosurgery (SRS).

Conditions

Interventions

OTHER

MRI

Subjects undergo one additional delayed MRI sequence

Sponsors & Collaborators

Principal Investigators

  • Scott Floyd, M.D. Ph.D. · Duke Health

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-19
Primary Completion
2025-03-19
Completion
2027-03-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04246879 on ClinicalTrials.gov